Efficacy and Safety of Chidamide in CBF Leukemia

NCT03031262 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

AML

Interventions

DRUG: Cytarabine
DRUG: Chidamide

Sponsor

Institute of Hematology & Blood Diseases Hospital, China